Evidence map›Paper›PMID 27729033›Full record

ArticleBMC cancer2016

Capsaicin mediates caspases activation and induces apoptosis through P38 and JNK MAPK pathways in human renal carcinoma.

Tao Liu, Gang Wang, Huangheng Tao, Zhonghua Yang, Yongzhi Wang, Zhe Meng, Rui Cao, Yu Xiao, Xinghuan Wang, Jiajie Zhou

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. The Impact of TRPV1 on Cancer Pathogenesis and Therapy: A Systematic Review.International journal of biological sciences · 2021
    Pooled it
  2. Article
  3. Journal of Zhejiang University. Science. B · 2026
    Review
  4. Metal Ion Signaling in Biomedicine.Chemical reviews · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Capsaicin: Emerging Pharmacological and Therapeutic Insights.Current issues in molecular biology · 2024
    Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Tao LiuDepartment of Urology, Jingzhou Central Hospital, the Second Clinical Medical College, Yangtze University, Jingzhou, 434020, China.
Gang WangDepartment of Urology, Zhongnan Hospital of Wuhan University, Center for Medical Science Research, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Huangheng TaoDepartment of Endodontics, Stomatology of Wuhan University, Wuhan, 430079, China.
Zhonghua YangDepartment of Urology, Zhongnan Hospital of Wuhan University, Center for Medical Science Research, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Yongzhi WangDepartment of Urology, Zhongnan Hospital of Wuhan University, Center for Medical Science Research, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Zhe MengDepartment of Urology, Zhongnan Hospital of Wuhan University, Center for Medical Science Research, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Rui CaoDepartment of Urology, Zhongnan Hospital of Wuhan University, Center for Medical Science Research, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Yu XiaoDepartment of Urology, Zhongnan Hospital of Wuhan University, Center for Medical Science Research, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Xinghuan WangDepartment of Urology, Zhongnan Hospital of Wuhan University, Center for Medical Science Research, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. wangxinghuan@whu.edu.cn.
Jiajie ZhouDepartment of Urology, Jingzhou Central Hospital, the Second Clinical Medical College, Yangtze University, Jingzhou, 434020, China. zhoujiajiejingzhou@126.com.
Wuhan University · CNZhongnan Hospital of Wuhan University · CNJingzhou Central Hospital · CNYangtze University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRenal cell carcinoma (RCC) is one of the tumors most refractory to chemotherapy to date. Therefore, novel therapeutic agents are urgently needed for this disease. Capsaicin (CPS), a natural active ingredient of green and red peppers, and a ligand of transient receptor potential vanilloid type 1 (TRPV1), has been showed potential in suppression of tumorigenesis of several cancers. Nonetheless, the anti-cancer activity of CPS has never been studied in human RCC.

methodsCCK8 analysis, LDH release activity and ROS generation analysis, flow cytometry analysis, and nuclear staining test were performed to test the influence of CPS in cultured cells in vitro, meanwhile western blot was done to uncover the precise molecular mechanisms. 786-O renal cancer xenografts were builded to investigate the antitumor activity of CPS in vivo.

resultsWe found treatment of CPS reduced proliferation of renal carcinoma cells, which could be attenuated by TRPV1 representative antagonist capsazepine (CPZ). CPS induced obvious apoptosis in renal carcinoma cells. These events were associated with substantial up-regulation of pro-apoptotic genes including c-myc, FADD, Bax and cleaved-caspase-3, -8, and -9, while down-regulation of anti-apoptotic gene Bcl2. Besides, CPS-treatment activated P38 and JNK MAPK pathways, yet P38 and JNK inhibitors afforded protection against CPS-induced apoptosis by abolishing activation of caspase-3, -8, and -9. Furthermore, CPS significantly slowed the growth of 786-O renal cancer xenografts in vivo.

conclusionsSuch results reveal that CPS is an efficient and potential drug for management of human RCC.

Indexed as

AnimalsAntineoplastic Agents, PhytogenicApoptosisCapsaicinCarcinoma, Renal CellCaspasesCell Line, TumorDisease Models, AnimalHumansLactate DehydrogenasesMAP Kinase Signaling SystemMiceMitogen-Activated Protein Kinasesp38 Mitogen-Activated Protein KinasesReactive Oxygen SpeciesXenograft Model Antitumor AssaysAntineoplastic Agents, PhytogenicCapsaicinCaspasesLactate DehydrogenasesMitogen-Activated Protein Kinasesp38 Mitogen-Activated Protein KinasesReactive Oxygen SpeciesApoptosisCapsaicinCaspasesMAPKRenal cell carcinomaTRPV1

Identifiers

PMID27729033
PMCPMC5059898
OpenAlexW2530611671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.